-
1
-
-
0038645309
-
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR trial)
-
STELLAR Study Group J.W.
-
P.H. Jones, M.H. Davidson, E.A. Stein, H.E. Bays, J.M. McKenney, E. Miller, V.A. Cain, J.W. Blasetto STELLAR Study Group Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR trial) Am J Cardiol 92 2003 152 160
-
(2003)
Am J Cardiol
, vol.92
, pp. 152-160
-
-
Jones, P.H.1
Davidson, M.H.2
Stein, E.A.3
Bays, H.E.4
McKenney, J.M.5
Miller, E.6
Cain, V.A.7
Blasetto8
-
2
-
-
19344367431
-
-
First DataBank. June
-
First DataBank. June 2004. Available at: www.firstdatabank.com. Accessed on June 8, 2004.
-
(2004)
-
-
-
3
-
-
0036910821
-
Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial
-
Rosuvastatin Study Group E.
-
W.V. Brown, H.E. Bays, D.R. Hassman, J. McKenney, R. Chitra, H. Hutchinson, E. Miller Rosuvastatin Study Group Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial Am Heart J 144 2002 1036 1043
-
(2002)
Am Heart J
, vol.144
, pp. 1036-1043
-
-
Brown, W.V.1
Bays, H.E.2
Hassman, D.R.3
McKenney, J.4
Chitra, R.5
Hutchinson, H.6
Miller7
-
4
-
-
0036915307
-
Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia
-
Rosuvastatin Investigators Group J.W.
-
A.G. Olsson, H. Istad, O. Luurila, L. Ose, S. Stender, J. Tuomilehto, O. Wiklund, H. Southworth, J. Pears, J.W. Wilpshaar Rosuvastatin Investigators Group Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia Am Heart J 144 2002 1044 1051
-
(2002)
Am Heart J
, vol.144
, pp. 1044-1051
-
-
Olsson, A.G.1
Istad, H.2
Luurila, O.3
Ose, L.4
Stender, S.5
Tuomilehto, J.6
Wiklund, O.7
Southworth, H.8
Pears, J.9
Wilpshaar10
-
6
-
-
0001994993
-
Handling uncertainty in economic evaluation and presenting the results
-
M. Drummond A. McGuire Oxford University Press/Office of Health Economics Oxford
-
A. Briggs Handling uncertainty in economic evaluation and presenting the results M. Drummond A. McGuire Economic Evaluation in Health Care--Merging Theory With Practice 2001 Oxford University Press/Office of Health Economics Oxford 172 214
-
(2001)
Economic Evaluation in Health Care--Merging Theory With Practice
, pp. 172-214
-
-
Briggs, A.1
-
7
-
-
0031900689
-
Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis
-
A.A. Stinnett, J. Mullahy Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis Med Decis Making 18 suppl 1998 S68 S80
-
(1998)
Med Decis Making
, vol.18
, Issue.SUPPL.
-
-
Stinnett, A.A.1
Mullahy, J.2
-
9
-
-
1542437305
-
Determinants of the cost-effectiveness of statins
-
A. Morrison, H. Glassberg Determinants of the cost-effectiveness of statins J Manag Care Pharm 9 2003 544 551
-
(2003)
J Manag Care Pharm
, vol.9
, pp. 544-551
-
-
Morrison, A.1
Glassberg, H.2
-
10
-
-
18144444323
-
Cost-effectiveness of statins
-
D.M. Huse, M.W. Russell, J.D. Miller, D.F. Kraemer, R.B. D'Agostino, R.C. Ellison, S.C. Hartz Cost-effectiveness of statins Am J Cardiol 82 1998 1357 1363
-
(1998)
Am J Cardiol
, vol.82
, pp. 1357-1363
-
-
Huse, D.M.1
Russell, M.W.2
Miller, J.D.3
Kraemer, D.F.4
D'Agostino, R.B.5
Ellison, R.C.6
Hartz, S.C.7
-
11
-
-
0033198903
-
Comparative cost-effectiveness of HMG-CoA reductase inhibitors in secondary prevention of acute myocardial infarction
-
W.J. Elliott, D.R. Weir Comparative cost-effectiveness of HMG-CoA reductase inhibitors in secondary prevention of acute myocardial infarction Am J Health Syst Pharm 56 1999 1726 1732
-
(1999)
Am J Health Syst Pharm
, vol.56
, pp. 1726-1732
-
-
Elliott, W.J.1
Weir, D.R.2
-
12
-
-
0037422116
-
Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups
-
J.W. Blasetto, E.A. Stein, W.V. Brown, R. Chitra, A. Raza Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups Am J Cardiol 91 suppl 5A 2003 3C 10C
-
(2003)
Am J Cardiol
, vol.91
, Issue.SUPPL. 5A
-
-
Blasetto, J.W.1
Stein, E.A.2
Brown, W.V.3
Chitra, R.4
Raza, A.5
-
13
-
-
0037422072
-
Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals
-
J. Shepherd, D.B. Hunninghake, P. Barter, J.M. McKenney, H.G. Hutchinson Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals Am J Cardiol 91 suppl 2003 11C 19C
-
(2003)
Am J Cardiol
, vol.91
, Issue.SUPPL.
-
-
Shepherd, J.1
Hunninghake, D.B.2
Barter, P.3
McKenney, J.M.4
Hutchinson, H.G.5
-
14
-
-
0030967489
-
Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia: Atorvastatin Study Group I
-
M. Davidson, J. McKenney, E. Stein, H. Schrott, R. Bakker-Arkema, R. Fayyad, D. Black Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia Atorvastatin Study Group I Am J Cardiol 79 1997 1475 1481
-
(1997)
Am J Cardiol
, vol.79
, pp. 1475-1481
-
-
Davidson, M.1
McKenney, J.2
Stein, E.3
Schrott, H.4
Bakker-Arkema, R.5
Fayyad, R.6
Black, D.7
-
15
-
-
0037223771
-
Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease
-
D.W. Schneck, R.H. Knopp, C.M. Ballantyne, R. McPherson, R.R. Chitra, S.G. Simonson Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease Am J Cardiol 91 2003 33 41
-
(2003)
Am J Cardiol
, vol.91
, pp. 33-41
-
-
Schneck, D.W.1
Knopp, R.H.2
Ballantyne, C.M.3
McPherson, R.4
Chitra, R.R.5
Simonson, S.G.6
-
16
-
-
2542582855
-
Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study
-
MERCURY I Study Group A.
-
H. Schuster, P.J. Barter, S. Stender, R.C. Cheung, J. Bonnet, J.M. Morrell, C. Watkins, D. Kallend, A. Raza MERCURY I Study Group Effects of switching statins on achievement of lipid goals Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study Am Heart J 147 2004 705 713
-
(2004)
Am Heart J
, vol.147
, pp. 705-713
-
-
Schuster, H.1
Barter, P.J.2
Stender, S.3
Cheung, R.C.4
Bonnet, J.5
Morrell, J.M.6
Watkins, C.7
Kallend, D.8
Raza9
-
17
-
-
0034723758
-
The Lipid Treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
-
T.A. Pearson, I. Laurora, H. Chu, S. Kafonek The Lipid Treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals Arch Intern Med 160 2000 459 467
-
(2000)
Arch Intern Med
, vol.160
, pp. 459-467
-
-
Pearson, T.A.1
Laurora, I.2
Chu, H.3
Kafonek, S.4
-
18
-
-
0031195278
-
A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia
-
A. Dart, G. Jerums, G. Nicholson, M. d'Emden, I. Hamilton-Craig, G. Tallis, J. Best, M. West, D. Sullivan, P. Bracs, D. Black A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia Am J Cardiol 80 1997 39 44
-
(1997)
Am J Cardiol
, vol.80
, pp. 39-44
-
-
Dart, A.1
Jerums, G.2
Nicholson, G.3
D'Emden, M.4
Hamilton-Craig, I.5
Tallis, G.6
Best, J.7
West, M.8
Sullivan, D.9
Bracs, P.10
Black, D.11
-
19
-
-
0036467895
-
Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia
-
M. Davidson, P. Ma, E.A. Stein, A.M. Gotto Jr, A. Raza, R. Chitra, H. Hutchinson Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia Am J Cardiol 89 2002 268 275
-
(2002)
Am J Cardiol
, vol.89
, pp. 268-275
-
-
Davidson, M.1
Ma, P.2
Stein, E.A.3
Gotto A.M. Jr4
Raza, A.5
Chitra, R.6
Hutchinson, H.7
-
20
-
-
3042794762
-
Safety and efficacy of rosuvastatin
-
G.O. Olsson Safety and efficacy of rosuvastatin Lancet 364 2004 135
-
(2004)
Lancet
, vol.364
, pp. 135
-
-
Olsson, G.O.1
-
21
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
-
Scandinavian Simvastatin Survival Study Group
-
Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
22
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group
-
J. Shepherd, S.M. Cobbe, I. Ford, C.G. Isles, A.R. Lorimer, P.W. MacFarlane, J.H. McKillop, C.J. Packard Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia West of Scotland Coronary Prevention Study Group N Engl J Med 333 1995 1301 1307
-
(1995)
N Engl J Med
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, I.3
Isles, C.G.4
Lorimer, A.R.5
MacFarlane, P.W.6
McKillop, J.H.7
Packard, C.J.8
-
23
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators
-
F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, T.G. Cole, L. Brown, J.W. Warnica, J.M. Arnold, C.C. Wun The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1996 1001 1009
-
(1996)
N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
Rouleau, J.L.4
Rutherford, J.D.5
Cole, T.G.6
Brown, L.7
Warnica, J.W.8
Arnold, J.M.9
Wun, C.C.10
-
24
-
-
0032572086
-
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
-
AFCAPS/TexCAPS Research Group
-
J.R. Downs, M. Clearfield, S. Weis, E. Whitney, D.R. Shapiro, P.A. Beere, A. Langendorfer, E.A. Stein, W. Kruyer, A.M. Gotto Jr AFCAPS/TexCAPS Research Group Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels Results of AFCAPS/TexCAPS JAMA 279 1998 1615 1622
-
(1998)
JAMA
, vol.279
, pp. 1615-1622
-
-
Downs, J.R.1
Clearfield, M.2
Weis, S.3
Whitney, E.4
Shapiro, D.R.5
Beere, P.A.6
Langendorfer, A.7
Stein, E.A.8
Kruyer, W.9
Gotto A.M. Jr10
-
25
-
-
0037031061
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial
-
Heart Protection Study Collaborative Group
-
Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
-
26
-
-
0037178569
-
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial
-
Lescol Intervention Prevention Study (LIPS) Investigators B.
-
P.W. Serruys, P. de Feyter, C. Macaya, N. Kokott, J. Puel, M. Vrolix, A. Branzi, M.C. Bertolami, G. Jackson, B. Strauss, B. Meier Lescol Intervention Prevention Study (LIPS) Investigators Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial JAMA 287 2002 3215 3222
-
(2002)
JAMA
, vol.287
, pp. 3215-3222
-
-
Serruys, P.W.1
De Feyter, P.2
Macaya, C.3
Kokott, N.4
Puel, J.5
Vrolix, M.6
Branzi, A.7
Bertolami, M.C.8
Jackson, G.9
Strauss, B.10
Meier11
|